{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T21:08:38Z","timestamp":1784063318482,"version":"3.55.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2011,4,1]],"date-time":"2011-04-01T00:00:00Z","timestamp":1301616000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,4,1]],"date-time":"2011-04-01T00:00:00Z","timestamp":1301616000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2011,4,1]],"date-time":"2011-04-01T00:00:00Z","timestamp":1301616000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2011,4,1]],"date-time":"2011-04-01T00:00:00Z","timestamp":1301616000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2011,4,1]],"date-time":"2011-04-01T00:00:00Z","timestamp":1301616000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2011,4,1]],"date-time":"2011-04-01T00:00:00Z","timestamp":1301616000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2011,4,1]],"date-time":"2011-04-01T00:00:00Z","timestamp":1301616000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids"],"published-print":{"date-parts":[[2011,4]]},"DOI":"10.1016\/j.bbalip.2011.01.002","type":"journal-article","created":{"date-parts":[[2011,1,14]],"date-time":"2011-01-14T07:21:42Z","timestamp":1294989702000},"page":"227-233","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"title":["Inhibition of the isoprenoid biosynthesis pathway; detection of intermediates by UPLC\u2013MS\/MS"],"prefix":"10.1016","volume":"1811","author":[{"given":"Linda","family":"Henneman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arno G.","family":"van Cruchten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Willem","family":"Kulik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans R.","family":"Waterham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbalip.2011.01.002_bb0005","doi-asserted-by":"crossref","first-page":"5289","DOI":"10.1074\/jbc.271.10.5289","article-title":"Protein prenyltransferases","volume":"271","author":"Casey","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2011.01.002_bb0010","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s00018-005-5298-6","article-title":"Isoprenylated proteins","volume":"63","author":"McTaggart","year":"2006","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.bbalip.2011.01.002_bb0015","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/343425a0","article-title":"Regulation of the mevalonate pathway","volume":"343","author":"Goldstein","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.bbalip.2011.01.002_bb0020","doi-asserted-by":"crossref","first-page":"403","DOI":"10.2165\/00003088-199732050-00005","article-title":"Pharmacodynamics and pharmacokinetics of the HMG-CoA reductase inhibitors. Similarities and differences","volume":"32","author":"Lennernas","year":"1997","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.bbalip.2011.01.002_bb0025","doi-asserted-by":"crossref","first-page":"467","DOI":"10.2174\/138161209787315684","article-title":"Statins and cardiovascular diseases: from cholesterol lowering to pleiotropy","volume":"15","author":"Zhou","year":"2009","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.bbalip.2011.01.002_bb0030","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/s00198-007-0540-8","article-title":"Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy","volume":"19","author":"Russell","year":"2008","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.bbalip.2011.01.002_bb0035","doi-asserted-by":"crossref","first-page":"479","DOI":"10.2174\/138161209787315729","article-title":"Pleiotropic effects of statins\u2014clinical evidence","volume":"15","author":"Athyros","year":"2009","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.bbalip.2011.01.002_bb0040","doi-asserted-by":"crossref","first-page":"164","DOI":"10.3109\/07853890008998823","article-title":"Non-lipid-related effects of statins","volume":"32","author":"Bellosta","year":"2000","journal-title":"Ann. Med."},{"key":"10.1016\/j.bbalip.2011.01.002_bb0045","first-page":"10","article-title":"The statins as anticancer agents","volume":"9","author":"Chan","year":"2003","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbalip.2011.01.002_bb0050","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1002\/jor.20129","article-title":"Anticancer effects of zoledronic acid against human osteosarcoma cells","volume":"24","author":"Kubista","year":"2006","journal-title":"J. Orthop. Res."},{"key":"10.1016\/j.bbalip.2011.01.002_bb0055","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1038\/sj.bjc.6600986","article-title":"Zoledronic acid induces antiproliferative and apoptotic effects in human pancreatic cancer cells in vitro","volume":"88","author":"Tassone","year":"2003","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bbalip.2011.01.002_bb0060","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.jhep.2005.09.022","article-title":"Pamidronate induced anti-proliferative, apoptotic, and anti-migratory effects in hepatocellular carcinoma","volume":"44","author":"Wada","year":"2006","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bbalip.2011.01.002_bb0065","doi-asserted-by":"crossref","first-page":"807","DOI":"10.2174\/156800909789760339","article-title":"Anti-tumour effects of bisphosphonates\u2014what have we learned from in vivo models?","volume":"9","author":"Brown","year":"2009","journal-title":"Curr. Cancer Drug Targets"},{"key":"10.1016\/j.bbalip.2011.01.002_bb0070","doi-asserted-by":"crossref","first-page":"301","DOI":"10.2174\/1389450053765833","article-title":"Isoprenylation of intracellular proteins as a new target for the therapy of human neoplasms: preclinical and clinical implications","volume":"6","author":"Caraglia","year":"2005","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.bbalip.2011.01.002_bb0075","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.2174\/0929867024606687","article-title":"Protein farnesyltransferase inhibitors","volume":"9","author":"Ayral-Kaloustian","year":"2002","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.bbalip.2011.01.002_bb0080","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1172\/JCI30868","article-title":"GGTase-I deficiency reduces tumor formation and improves survival in mice with K-RAS-induced lung cancer","volume":"117","author":"Sjogren","year":"2007","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbalip.2011.01.002_bb0085","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1097\/CRD.0b013e3181885905","article-title":"Pharmacologic inhibition of squalene synthase and other downstream enzymes of the cholesterol synthesis pathway: a new therapeutic approach to treatment of hypercholesterolemia","volume":"17","author":"Seiki","year":"2009","journal-title":"Cardiol. Rev."},{"key":"10.1016\/j.bbalip.2011.01.002_bb0090","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ab.2008.08.023","article-title":"Detection of nonsterol isoprenoids by HPLC\u2013MS\/MS","volume":"383","author":"Henneman","year":"2008","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.bbalip.2011.01.002_bb0095","doi-asserted-by":"crossref","first-page":"7821","DOI":"10.1021\/jo00129a023","article-title":"A stereoselective palladium\/copper-catalyzed route to isoprenoids: synthesis and biological evaluation of 13-methylidenefarnesyl diphosphate","volume":"60","author":"Gibbs","year":"1995","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.bbalip.2011.01.002_bb0100","doi-asserted-by":"crossref","first-page":"7153","DOI":"10.1021\/ja000860f","article-title":"Evaluation of isoprenoid conformation in solution and in the active site of protein-farnesyl transferase using carbon-13 labeling in conjunction with solution- and solid-state NMR","volume":"122","author":"Zahn","year":"2000","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.bbalip.2011.01.002_bb0105","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.1002\/art.21960","article-title":"Manipulation of isoprenoid biosynthesis as a possible therapeutic option in mevalonate kinase deficiency","volume":"54","author":"Schneiders","year":"2006","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.bbalip.2011.01.002_bb0110","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/0003-2697(85)90442-7","article-title":"Measurement of protein using bicinchoninic acid","volume":"150","author":"Smith","year":"1985","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.bbalip.2011.01.002_bb0115","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/S0022-2275(20)43173-6","article-title":"3-Hydroxy-3-methylglutaryl coenzyme A reductase activity in cultured fibroblasts from patients with mevalonate kinase deficiency: differential response to lipid supplied by fetal bovine serum in tissue culture medium","volume":"31","author":"Gibson","year":"1990","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbalip.2011.01.002_bb0120","doi-asserted-by":"crossref","first-page":"209","DOI":"10.2174\/157488609789006949","article-title":"Adverse effects of statins\u2014mechanisms and consequences","volume":"4","author":"Beltowski","year":"2009","journal-title":"Curr. Drug Saf."},{"key":"10.1016\/j.bbalip.2011.01.002_bb0125","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.1016\/S0022-2275(20)34935-X","article-title":"Post-translational regulation of mevalonate kinase by intermediates of the cholesterol and nonsterol isoprene biosynthetic pathways","volume":"38","author":"Hinson","year":"1997","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbalip.2011.01.002_bb0130","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1042\/bj2270247","article-title":"Mechanism of the inhibition of cholesterol biosynthesis by 6-fluoromevalonate","volume":"227","author":"Nave","year":"1985","journal-title":"Biochem. J."},{"key":"10.1016\/j.bbalip.2011.01.002_bb0135","doi-asserted-by":"crossref","first-page":"638","DOI":"10.2174\/138955709788452702","article-title":"Farnesyltransferase inhibitor as anticancer agent","volume":"9","author":"Agrawal","year":"2009","journal-title":"Mini. Rev. Med. Chem."},{"key":"10.1016\/j.bbalip.2011.01.002_bb0140","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1158\/1535-7163.MCT-08-1122","article-title":"In vivo antitumor effect of a novel inhibitor of protein geranylgeranyltransferase-I","volume":"8","author":"Lu","year":"2009","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.bbalip.2011.01.002_bb0145","doi-asserted-by":"crossref","first-page":"4667","DOI":"10.1016\/S0021-9258(18)93170-4","article-title":"The inhibition of mevalonic kinase by geranyl and farnesyl pyrophosphates","volume":"243","author":"Dorsey","year":"1968","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2011.01.002_bb0150","doi-asserted-by":"crossref","first-page":"25449","DOI":"10.1074\/jbc.272.41.25449","article-title":"Identification of catalytic residues in human mevalonate kinase","volume":"272","author":"Potter","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2011.01.002_bb0155","doi-asserted-by":"crossref","first-page":"3235","DOI":"10.1021\/bi052231u","article-title":"Phosphomevalonate kinase: functional investigation of the recombinant human enzyme","volume":"45","author":"Herdendorf","year":"2006","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbalip.2011.01.002_bb0160","doi-asserted-by":"crossref","first-page":"4510","DOI":"10.1074\/jbc.M210551200","article-title":"The kinetic mechanism of phosphomevalonate kinase","volume":"278","author":"Pilloff","year":"2003","journal-title":"J. Biol. Chem."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1388198111000047?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1388198111000047?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T09:54:59Z","timestamp":1761386099000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1388198111000047"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4]]},"references-count":32,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,4]]}},"alternative-id":["S1388198111000047"],"URL":"https:\/\/doi.org\/10.1016\/j.bbalip.2011.01.002","relation":{},"ISSN":["1388-1981"],"issn-type":[{"value":"1388-1981","type":"print"}],"subject":[],"published":{"date-parts":[[2011,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhibition of the isoprenoid biosynthesis pathway; detection of intermediates by UPLC\u2013MS\/MS","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbalip.2011.01.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}